Nils Siegbahn

Nils Siegbahn

Director/Board Member presso GLYCOREX TRANSPLANTATION AB

71 anni
Health Technology
Consumer Services
Process Industries

Profilo

Nils Siegbahn is currently a Director at Glycorex Transplantation AB and a Director at Sparbanksstiftelsen Skånes Riskkapitalstiftelse.
He was previously the Chief Executive Officer at Pernovo AB, Chairman at Glycorex Transplantation AB, Managing Director at Niconovum AB, President at Alligator Bioscience AB, Director-Special Projects at Perstorp Holding AB, Director at Atos Medical AB, Director at Celltrix AB, and Independent Director at Enzymatica AB.
Dr. Siegbahn holds a graduate degree from Stockholm School of Economics and a doctorate degree from the Faculty of Engineering, Lund University.

Posizioni attive di Nils Siegbahn

SocietàPosizioneInizio
GLYCOREX TRANSPLANTATION AB Director/Board Member 01/01/2021
Director/Board Member -
Tutte le posizioni attive di Nils Siegbahn

Precedenti posizioni note di Nils Siegbahn

SocietàPosizioneFine
ENZYMATICA AB Director/Board Member 19/12/2016
GLYCOREX TRANSPLANTATION AB Chairman 01/01/2009
ALLIGATOR BIOSCIENCE AB President 01/07/2004
Corporate Officer/Principal -
Director/Board Member -
Vedi nel dettaglio l'esperienza di Nils Siegbahn

Formazione di Nils Siegbahn

Stockholm School of Economics Graduate Degree
Faculty of Engineering, Lund University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Nils Siegbahn

Relazioni

32

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
GLYCOREX TRANSPLANTATION AB

Health Technology

ALLIGATOR BIOSCIENCE AB

Health Technology

ENZYMATICA AB

Health Technology

Aziende private6

Health Technology

Process Industries

Pernovo AB

Health Technology

Commercial Services

Finance

Vedi le connessioni aziendali